UBS Group’s Agile Therapeutics, Inc AGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,387
Closed -$2.71K 9009
2023
Q4
$2.71K Buy
+1,387
New +$2.71K ﹤0.01% 6849
2023
Q3
Sell
-24
Closed -$71 9060
2023
Q2
$71 Buy
+24
New +$71 ﹤0.01% 7476
2023
Q1
Hold
0
-$1 8419
2022
Q4
Sell
-1,103
Closed -$16K 9468
2022
Q3
$16K Buy
1,103
+593
+116% +$8.6K ﹤0.01% 6656
2022
Q2
$30K Buy
510
+482
+1,721% +$28.4K ﹤0.01% 5383
2022
Q1
$12K Buy
28
+26
+1,300% +$11.1K ﹤0.01% 7193
2021
Q4
$2K Buy
+2
New +$2K ﹤0.01% 8761
2021
Q3
Hold
0
-$1K 9070
2021
Q2
Sell
-7
Closed -$28K 8135
2021
Q1
$28K Hold
7
﹤0.01% 6061
2020
Q4
$42K Buy
+7
New +$42K ﹤0.01% 5349
2020
Q3
Sell
-11
Closed -$61K 6707
2020
Q2
$61K Buy
+11
New +$61K ﹤0.01% 4874
2020
Q1
Sell
-2
Closed -$12K 7342
2019
Q4
$12K Buy
+2
New +$12K ﹤0.01% 6129
2019
Q3
Sell
-3
Closed -$9K 7251
2019
Q2
$9K Hold
3
﹤0.01% 6275
2019
Q1
$9K Sell
3
-3
-50% -$9K ﹤0.01% 6065
2018
Q4
$7K Buy
+6
New +$7K ﹤0.01% 6511
2018
Q3
Sell
-2
Closed -$1K 7249
2018
Q2
$1K Hold
2
﹤0.01% 6927
2018
Q1
$10K Buy
+2
New +$10K ﹤0.01% 6005
2017
Q4
Sell
-1
Closed -$4K 7043
2017
Q3
$4K Hold
1
﹤0.01% 6414
2017
Q2
$8K Buy
+1
New +$8K ﹤0.01% 5990
2017
Q1
Sell
-2
Closed -$17K 6557
2016
Q4
$17K Buy
+2
New +$17K ﹤0.01% 5671
2016
Q3
Hold
0
-$3K 6211
2016
Q2
Hold
0
-$6K 6443
2016
Q1
Sell
-2
Closed -$39K 6087
2015
Q4
$39K Buy
2
+1
+100% +$19.5K ﹤0.01% 4964
2015
Q3
$19K Hold
1
﹤0.01% 5497
2015
Q2
$19K Hold
1
﹤0.01% 5541
2015
Q1
$16K Buy
+1
New +$16K ﹤0.01% 5568
2014
Q4
Hold
0
6533